Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: Preliminary results from the prospective observational Vax-On study

Ann Oncol. 2021 Sep 20:S0923-7534(21)04488-4. doi: 10.1016/j.annonc.2021.09.009. Online ahead of print.NO ABSTRACTPMID:34555502 | PMC:PMC8452134 | DOI:10.1016/j.annonc.2021.09.009

Source: Ann Oncol - September 23, 2021 Category: Cancer & Oncology Authors: F Nelli A Fabbri A Onorato D Giannarelli M A Silvestri J R Giron Berrios A Virtuoso E Marrucci C Signorelli M G Chilelli F Primi M Schirripa M Mazzotta E M Ruggeri Source Type: research